| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 09/21/1999 | US5955477 Methods for treating gastrointestinal motility dysfunction using optically pure (--) cisapride |
| 09/21/1999 | US5955466 Tamoxifen as a therapy to reduce irinotecan hydrochloride-induced diarrhea |
| 09/21/1999 | US5955456 Injectable pharmaceutical composition comprising ursodesoxycholic acid or tauroursodesoxycholic acid, a strong base and tromethamol |
| 09/21/1999 | US5955443 Treatment and diagnosis of diseases or disorders amenable to treatment through modulation of expression of a nucleic acid encoding a platelet endothelial cell adhesion molecule-1 (pecam-1; also known as cd31 antigen or endocam) protein are |
| 09/21/1999 | US5955309 Polynucleotide encoding G-protein coupled receptor (H7TBA62) |
| 09/21/1999 | US5955308 cDNA clone HEAOD54 that encodes a human 7-transmembrane receptor |
| 09/21/1999 | CA2192975C Benzimidazolone derivatives |
| 09/21/1999 | CA2145313C Antimicrobial peptides |
| 09/16/1999 | WO1999046289A1 31 human secreted proteins |
| 09/16/1999 | WO1999046272A1 Serine peptidase modulators |
| 09/16/1999 | WO1999046248A1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors |
| 09/16/1999 | WO1999046245A2 PROCESSES FOR THE PREPARATION OF (R)-α- (2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL |
| 09/16/1999 | WO1999045955A1 DIAGNOSIS, PREVENTION AND TREATMENT OF ULCERATIVE COLITIS, AND CLINICAL SUBTYPES THEREOF, USING MICROBIAL UC pANCA ANTIGENS |
| 09/16/1999 | WO1999045916A2 Novel methods for treating disorders in which docosahexaenoic acid (dha) levels are affected |
| 09/16/1999 | WO1999045910A2 Methods and compositions for treating and preventing mucositis |
| 09/16/1999 | WO1999045788A1 Food products having enhanced cocoa polyphenol content and processes for producing same |
| 09/16/1999 | WO1999029878A3 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system |
| 09/16/1999 | CA2587736A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 09/16/1999 | CA2322848A1 Novel methods for treating disorders in which docosahexaenoic acid (dha) levels are effected |
| 09/16/1999 | CA2322728A1 31 human secreted proteins |
| 09/15/1999 | EP0941341A1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy |
| 09/15/1999 | EP0941333A1 Immunogenic detoxified mutant e. coli lt-a toxin |
| 09/15/1999 | EP0941330A1 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) |
| 09/15/1999 | EP0941323A1 Bone morphogenetic protein-16 (bmp-16) compositions |
| 09/15/1999 | EP0941249A1 Novel histamine h2 receptor |
| 09/15/1999 | EP0941247A2 Peptide compounds useful for modulating fgf receptor activity |
| 09/15/1999 | EP0941110A1 Uses of keratinocyte growth factor-2 |
| 09/15/1999 | EP0941108A1 Wound healing and treatment of fibrosis |
| 09/15/1999 | EP0941090A1 Pharmaceutical compositions containing n-sulphonyl indolin derivatives |
| 09/15/1999 | EP0941089A2 Compositions and methods for treating or preventing inflammatory diseases |
| 09/15/1999 | EP0941080A2 Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents |
| 09/15/1999 | EP0804239B1 Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof |
| 09/15/1999 | EP0741697B1 Amino acid derivatives and their use as phospholipase a2 inhibitors |
| 09/15/1999 | EP0679194B1 Method to predict active growth of bacteria adhered to a surface |
| 09/15/1999 | EP0652767B1 Treatment of human lactation failure |
| 09/15/1999 | EP0593463B1 Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use |
| 09/15/1999 | CN1228780A Phosphinic acid amides as matrix metalloprotease inhibitors |
| 09/15/1999 | CN1228779A Spirocyclic metalloprotease inhibitors |
| 09/15/1999 | CN1228775A Benzofurans and benzopyrans as chronobiological agents |
| 09/15/1999 | CN1228773A Heterocyclic metalloprotease inhibitors |
| 09/15/1999 | CN1228772A Heterocyclic metalloprotease inhibitors |
| 09/15/1999 | CN1228771A 1,3-diheterocyclic metalloprotease inhibitors |
| 09/15/1999 | CN1228767A Bidentate metalloprotease inhibitors |
| 09/15/1999 | CN1228697A Method for in vivo reduction of iron levels and compositions useful therefor |
| 09/15/1999 | CN1228692A Locally administrable, biodegradable and sustained-release pharmaceutical composition for periodontitis and process for preparation thereof |
| 09/15/1999 | CN1228422A Process for preparing naphthyridones and intermediates |
| 09/15/1999 | CN1228414A New benzocyclobutane compounds, process for their preparation and pharmaceutical compositions containing them |
| 09/15/1999 | CN1228327A Traditional Chinese medicine for curing gastrointestinal disease |
| 09/15/1999 | CN1228320A Chinese patent drug for curing cirrhosis and splenceratosis disease |
| 09/15/1999 | CN1228318A Chinese patent drug for curing hepatitis B |
| 09/15/1999 | CN1228305A Food capable of improving liver function |
| 09/14/1999 | US5952511 Indolin-2-one derivatives |
| 09/14/1999 | US5952504 Reacting a sulfonated, halogenated or phosphonated 1,7-naphthyridine compounds with an aromatic amine derivative; antiulcer agent |
| 09/14/1999 | US5952382 Inhibiting the biological effects of an overregulation of retinoid acid receptors and/or of a hypervitaminosis a; treating skin disorder, eye vision defects, skin aging |
| 09/14/1999 | US5952380 Method for treating diarrhea |
| 09/14/1999 | US5952369 Pyrrolidinyl hydroxamic acid compounds and their production process |
| 09/14/1999 | US5952340 Use of granisetron for the treatment of postoperative nausea and vomiting |
| 09/14/1999 | US5952322 Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors |
| 09/14/1999 | US5952295 Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract |
| 09/14/1999 | US5951974 At least about 15%, preferably about 30%, of the interferon conjugates have a nonantigenic alkylpolyether attached to a preferential histidine residue; high activity; reacting an n-oxycarbonyloxyimide at acidic ph |
| 09/14/1999 | CA2150483C Pyrazoles and pyrazolopyrimidines |
| 09/10/1999 | WO1999045024A1 Cholenic acid amides and pharmaceutical compositions thereof |
| 09/10/1999 | WO1999045016A2 Novel prodrugs for phosphorus-containing compounds |
| 09/10/1999 | WO1999045009A1 Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors |
| 09/10/1999 | WO1999045004A1 Nitrate salt of anti-ulcer medicine |
| 09/10/1999 | WO1999044989A1 Matrix metalloproteinase inhibitors |
| 09/10/1999 | WO1999044643A1 Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles |
| 09/10/1999 | WO1999044620A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 09/10/1999 | WO1999044613A1 Pharmaceutical compositions containing in combination two antagonists selective of arginine-vassopressin v receptors, even of v1a and v2 receptors |
| 09/10/1999 | WO1999044602A1 Inflammatory cell inhibitors |
| 09/10/1999 | WO1999044595A2 Pharmaceutical compositions for ulcer |
| 09/10/1999 | WO1999044570A1 Desensitizing dental composition |
| 09/10/1999 | WO1999044440A1 Food compositions for preventing periodontosis or preventing the progression of periodontosis and method for preventing or treating periodontosis |
| 09/10/1999 | WO1999032099A3 Use of fucane for regulating the reconstruction of connective tissues |
| 09/10/1999 | WO1999031262A3 Needle-free injection of formulated nucleic acid molecules |
| 09/10/1999 | WO1999021617B1 Allosteric adenosine receptor modulators |
| 09/10/1999 | CA2322645A1 Desensitizing dental composition |
| 09/10/1999 | CA2322493A1 Nitrate salt of anti-ulcer medicine |
| 09/10/1999 | CA2322486A1 Inflammatory cell inhibitors |
| 09/10/1999 | CA2317502A1 Matrix metalloproteinase inhibitors |
| 09/08/1999 | EP0940391A2 Quinoline derivatives as tachykinin NK3 receptor antagonists |
| 09/08/1999 | EP0940386A1 Benzocyclobutan compounds, their process for preparation and pharmaceutical compositions containing them |
| 09/08/1999 | EP0939648A1 Rotavirus vaccine formulations |
| 09/08/1999 | EP0939633A1 Treatment of sepsis-induced acute renal failure and renal vasoconstriction and catecholamine-induced renal and mesenteric vasoconstriction |
| 09/08/1999 | EP0939623A1 Oral delayed immediate release formulation and method of preparation therefor |
| 09/08/1999 | EP0939613A1 Mouthwash comprising calcium and phosphate ions in supersaturated solution |
| 09/08/1999 | EP0730594B1 9-HYDROXY-PYRIDO [1,2-a]PYRIMIDIN-4-ONE ETHER DERIVATIVES |
| 09/08/1999 | EP0671943B1 Use of enzymes, especially bromelain, in the treatment of non-infectious diarrhoea |
| 09/08/1999 | EP0656906B1 A novel endothelial cell molecule mediating lymphocyte binding in man |
| 09/08/1999 | CN1228120A Phytase from bacillus subtilis, gene encoding said phytase, method for its production and use |
| 09/08/1999 | CN1228091A Substituted 6,6-hetero-bicyclic derivatives |
| 09/08/1999 | CN1228083A Arylsulfonylamino hydroxamic acid derivatives |
| 09/08/1999 | CN1228024A Use of K-252A derivative for treatment of peripheral or central nerve disorders, and cytokine overproduction |
| 09/08/1999 | CN1228018A Liposomal compositions and method of using them |
| 09/08/1999 | CN1227753A Powder for curing gastric ulcer |
| 09/08/1999 | CN1227752A Capsule for curing hepatitis B |
| 09/08/1999 | CN1227748A Process for preparing ultramicro infant medicine |
| 09/07/1999 | US5948824 Use of a chemical agent for reducing the changes in waistline and the effect of constipation due to the taking of other agents |
| 09/07/1999 | US5948818 Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids |
| 09/07/1999 | US5948804 Anaesthetic premedication |